{
    "code": "02020119",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020119",
    "time": "2016-11-18 19:47:30",
    "許可證字號": "衛署藥輸字第020119號",
    "註銷狀態": "已註銷",
    "註銷日期": "95\/05\/23",
    "註銷理由": "未展延而逾期者",
    "有效日期": "92\/10\/05",
    "發證日期": "82\/10\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202011904",
    "中文品名": "比效新靜脈注射液４００公絲\/５公撮",
    "英文品名": "PEFLACINE 400MG (I.V. INFUSION) INJECTION",
    "適應症": "成人由革蘭氏陰性菌及葡萄球菌引起的嚴重感染症。",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PEFLOXACINEMESYLATEDIHYDRATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  臺灣安萬特藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F150171000  HAUPT PHARMA LIVRON",
        "製造廠廠址": "1 RUE COMTE DE SINARD 26250-LIVRON FRANCE",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700808",
            "成分名稱": "PEFLOXACINE MESYLATE DIHYDRATE",
            "含量描述": "558.5",
            "含量": "558.5000000000",
            "單位": "MG"
        }
    ]
}